IP Library Granted Patent US 7,141,235
Granted Patent B2
US 7,141,235 · App. 09/941,395 · Granted Nov 28, 2006

Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,235
App. No.
09/941,395
Granted
Nov 28, 2006
Kind
B2
Abstract

A gas emulsion forming composition comprising a dry, hollow, particulate, approximately microspherical material permeated with a gas or gas mixture, which upon dissolution in aqueous liquid forms a gas emulsion comprising a plurality of bubbles surrounded by a layer of at least a first and a second surfactant, wherein the first surfactant consists essentially of a phospholipid or mixture of phospholipids having at least one acyl chain which comprises at least 10 carbon atoms, and comprising at least about 5% w/w of total surfactant, and wherein the second surfactant may or may not be a phospholipid and is more water soluble than the first surfactant; kits for preparing such microbubbles; and methods for using such microbubbles as contrast agents.

Claims (15)

1. A system for providing an ultrasound image of at least a part of an object or body comprising:

an ultrasound imaging apparatus;

a kit capable of producing a stabilized microbubble preparation, conprising an aqueous medium, a gas osmotic agent, at least one phospholipid surfactant having at least one acyl chain of at least 10 or more carbon atoms and at least a second surfactant, wherein upon the application of energy the phospholipid surrounds the gas osmotic agent to form a microbubble, wherein the gas osmotic agent is selected from the group consisting of perfluorobutane, perfluorocyclobutane, perfluoropentane, perfluorocyclopentane, perfluoromethylcyclobutane, perfluorohexane, perfluorocyclohexane, perfluoromethylcyclopentane, perfluorodimethylcyclobutane, perfluoroheptane, perfluorocycloheptane, perfluoromethylcyclohexane, perfluorodimethylcyclopentane, perfluorotrimethylcyclobutane, perfluorotriethylamine, perfluoropropane and perfluorohexane.

2. The system of claim 1 wherein the gas osmotic agent is selected from the group consisting of perfluoropropane and perfluorohexane.

3. The system of claim 1 wherein the kit further comprises a modifier gas selected from the group consisting of nitrogen, oxygen, carbon dioxide or mixtures thereof.

4. The system of claim 3 wherein the mixture of the gas osmotic agent and modifier gas is effective to stabilize the microbubble preparation.

5. The system of claim 3 wherein the modifier gas is air.

6. The system of claim 3 wherein the gas osmotic agent is perfluoropropane and the second gas is nitrogen.

7. The system of claim 1 wherein the aqueous solution contains sterile water.

8. The system of claim 1 wherein the microbubble further comprises air.

9. The system of claim 1 wherein the gas osmotic agent is perfluoropropane.

10. The system of claim 1 wherein the kit contains a head space containing perfluoropropane gas.

11. The system of claim 10 wherein the head space contains air.

12. The system of claim 1 wherein the energy applied is mechanical energy.

13. The system of claim 1 wherein the energy applied is sonic energy.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Feb 13, 2009
From: IMCOR PHARMACEUTICAL CO.; OXFORD BIOSCIENCE PARTNERS IV L.P.; MRNA FUND II L.P; MI3 L.P.
To: IMCOR PHARMACEUTICAL CO.
Reel/Frame 022266/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2009
From: IMCOR PHARMACEUTICAL CO.
To: TARGESON, INC.
Reel/Frame 022248/0907 →
RELEASE OF SECURITY INTEREST Recorded Jan 12, 2009
From: XMARK FUND, L.P.; XMARK FUND, LTD.
To: IMCOR PHARMACEUTICAL CO.
Reel/Frame 022086/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2004
From: ALLIANCE PHARMACEUTICAL CORP.
To: IMCOR PHARMACEUTICAL CO.
Reel/Frame 015286/0336 →
RELEASE OF SECURITY INTEREST Recorded Jun 20, 2003
From: BROWN SIMPSON PARTNERS I, LTD.; SDS MERCHANT FUND, L.P.; CASTLE CREEK HEALTHCARE INVESTORS, LLC; CCL FUND, LLC; CC LIFESCIENCE, LTD.
To: ALLIANCE PHARMACEUTICAL CORP.
Reel/Frame 014154/0571 →
RELEASE OF SECURITY INTEREST Recorded Jun 19, 2003
From: SDS MERCHANT FUND, L.P., AS COLLATERAL AGENT
To: ALLIANCE PHARMACEUTICAL CORP.
Reel/Frame 014146/0166 →
SECURITY INTEREST Recorded Jun 19, 2003
From: PHOTOGEN TECHNOLOGIES, INC.
To: MRNA FUND II L.P.; MI3, L.P.; OXFORD BIOSCIENCE PARTNERS IV L.P.
Reel/Frame 014172/0313 →
SECURITY AGREEMENT Recorded Jun 19, 2003
From: PHOTOGEN TECHNOLOGIES, INC.
To: XMARK FUND, L.P.; XMARK FUND, LTD.
Reel/Frame 014178/0153 →
RELEASE SECURITY INTEREST Recorded Jun 19, 2003
From: XMARK FUND, L.P.; XMARK FUND, LTD.
To: ALLIANCE PHARMACEUTICAL CORP.; XMARK FUND, LTD.
Reel/Frame 014178/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2003
From: ALLIANCE PHARMACEUTICALS CORP.
To: PHOTOGEN TECHNOLOGIES, INC.
Reel/Frame 014178/0171 →
SECURITY AGREEMENT Recorded Oct 10, 2002
From: ALLIANCE PHARMACEUTICAL CORP.
To: BROWN SIMPSON PARTNERS I, LTD.; SDS MERCHANT FUND, L.P.; CASTLE CREEK HEALTHCARE INVESTORS, LLC C/O CASTLE CREEK PARTNERS, LLC; CCL FUND, LLC C/O CASTLE CREEK LIFESCIENCE PARTNERS, LLC; CC LIFESCIENCE, LTD. C/O CASTLE CREEK LIFESCIENCE PARTNERS, LLC
Reel/Frame 013372/0372 →
SECURITY AGREEMENT Recorded Oct 9, 2002
From: ALLIANCE PHARMACEUTICAL CORP.
To: SDS MERCHANT FUND, L.P.
Reel/Frame 013362/0076 →
SECURITY INTEREST Recorded Jul 30, 2002
From: ALLIANCE PHARMACEUTICAL CORP.
To: XMARK FUND, L.P.
Reel/Frame 013137/0623 →